Skip to content
Screener
Cardiol Therapeutics logo

Cardiol Therapeutics

CRDL

Cardiol Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David G. Elsley, with a market cap of $125.2M.

Market cap
$125.16M+20.9%

We’re still putting together Cardiol Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Cardiol Therapeutics up the queue, and we’ll analyze its filings next.

Earnings

Q3 2026 report

November 12, 2026

Next report

Date not yet announced

Profile

CountryCanada
Listed2019
Employees17.0
CEODavid G. Elsley
FilingsSEC EDGAR